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Background: Cardiac allograft vasculopathy (CAV) is the main limiting factor of long-term survival after heart transplantation (HT). CAV affects both 
epicardial coronary vessels and microvasculature. Coronary flow reserve (CFR) by transthoracic Doppler echocardiography (TDE) is an independent 
predictor of death in HT patients. We aimed to correlate the microvascular remodeling, as assessed by endomyocardial biopsy (EMB), with CFR by 
TDE in HT patients with normal coronary angiograms.
methods: We studied 28 consecutive HT patients without angiographic CAV (25 male, aged 54±10 years at HT, time from HT 7.5±5 years). 
Coronary flow velocity in the left anterior descending coronary artery was detected by TDE at rest and during adenosine infusion. CFR was the ratio 
of hyperaemic diastolic flow velocity (DFV) to resting DFV. A CFR≤2.5 was considered abnormal. In the 1st year post-HT EMBs, myocytes diameter, 
fibrosis percentage, capillary density and microvascular remodeling (vessel media area/total vessel area ratio (%)) were evaluated by digital 
morphometry.
results: CFR was abnormal in 11 (39.2%) patients. Microvascular remodeling was higher in patients with CFR≤2.5 compared with patients with 
CFR>2.5 (72.3±8 vs 65.2±4.7 %, p<0.007). Myocytes diameter, fibrosis percentage and capillary density were similar in the two groups. Male gender 
prevalence, gender donor-recipient mismatch, age at HT, time from HT, hypertension and diabetes prevalences, and other CAV risk factors were 
comparable in the two groups.
conclusions: Our results suggest that coronary microvascular remodeling at EMBs may be the main predictor of abnormal CFR in HT patients. CFR 
by TDE may be an useful noninvasive tool in the evaluation of microvascular dysfunction/damage in HT. Further studies are warranted.
